RxDoctor Payments Data

Scott Kaiser, MD

Family Medicine · Denver, CONPI 1093799215

Payments from drug & device makers

$3,613in general payments, 2019–2025

Across 35 payments — averaging $103.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$3K
  • Exact Sciences$137
  • AstraZeneca$125
  • Inspire Medical Systems, Inc.$102
  • GSK$70
  • Phadia US Inc.$46
  • plus $335 from 14 others

What the payments were for

  • Food & beverage$78897%
  • Education$283%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,613 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$56,496
Medicare patients
167
Services billed
1,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin86$124,924
EliquisApixaban58$86,632
OzempicSemaglutide31$72,110
FarxigaDapagliflozin Propanediol40$63,941
XareltoRivaroxaban40$59,681
TrulicityDulaglutide33$59,140
MounjaroTirzepatide36$46,001
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$27,729
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$8,663
SymbicortBudesonide/Formoterol Fumarate21$8,643
Atorvastatin Calcium710$6,110
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$3,770
Levothyroxine Sodium372$3,113
Omeprazole143$3,062
Albuterol Sulfate HfaAlbuterol Sulfate48$2,423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$12$105,14169 claims
PfizerEliquis$17$86,63258 claims
AstraZenecaFarxiga, Symbicort$125$72,58461 claims
GSKTrelegy Ellipta$70$27,72920 claims
AbbVieSynthroid$45$1,54527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →